| Variable Category | Control | CIN 3 | Carcinoma | P* | |||
| n | (%) | n | (%) | n | (%) | ||
| Age (N = 514) |
|
|
|
|
|
| <0.001 |
| ・ <50 Y | 130 | (57.8) | 69 | (92.0) | 110 | (51.4) |
|
| ・ >50 Y | 95 | (42.2) | 06 | (08.0) | 104 | (48.6) |
|
| Total | 225 | (100) | 75 | (100) | 214 | (100) |
|
| Ethnicity (N = 247) |
|
|
|
|
|
| <0.001 |
| ・ White | 20 | (40.8) | 38 | (50.7) | 98 | (79.7) |
|
| ・ Black | 29 | (59.2) | 37 | (49.3) | 21 | (17.1) |
|
| ・ Asian | 0 | (0) | 0 | (0) | 04 | (03.3) |
|
| Total | 49 | (100) | 75 | (100) | 123 | (100) |
|
| Histological Type (N = 214) |
|
|
|
|
|
|
|
| ・ Squamous carcinoma |
|
|
|
| 112 | (91.1) |
|
| ・ Adenocarcinoma |
|
|
|
| 11 | (08.9) |
|
| ・ Unknown |
|
|
|
| 91 |
|
|
| Total |
|
|
|
| 214 | (100) |
|
| Gene FAS Polymorphism (N = 514) |
|
|
|
|
|
| 0.046 |
| ・ Wild (AA) | 53 | (23.5) | 08 | (10.7) | 52 | (24.3) |
|
| ・ Heterozygote (AG) | 112 | (49.8) | 50 | (66.7) | 104 | (48.6) |
|
| ・ Mutant (GG) | 60 | (26.7) | 17 | (22.6) | 58 | (27.1) |
|
| Total | 225 | (100) | 75 | (100) | 214 | (100) |
|